UBS Group AG - ONCOSEC MED INC ownership

ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 23 filers reported holding ONCOSEC MED INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCOSEC MED INC
ValueSharesWeighting
Q1 2022$9,000
+28.6%
8,185
+219.2%
0.00%
Q2 2021$7,000
+40.0%
2,564
+142.1%
0.00%
Q1 2021$5,000
-73.7%
1,059
-63.6%
0.00%
Q4 2020$19,000
+5.6%
2,911
-46.2%
0.00%
Q3 2020$18,000
+80.0%
5,408
-32.5%
0.00%
Q1 2020$10,000
+400.0%
8,010
+765.9%
0.00%
Q4 2019$2,0000.0%925
-9.8%
0.00%
Q3 2019$2,0000.0%1,025
+13.9%
0.00%
Q2 2019$2,0009000.00%
Other shareholders
ONCOSEC MED INC shareholders Q1 2020
NameSharesValueWeighting ↓
SALZHAUER MICHAEL 277,312$591,0000.24%
Avidity Partners Management LP 2,945,000$6,273,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 316,229$674,0000.12%
J. Goldman & Co LP 790,242$1,683,0000.08%
Sandbox Financial Partners, LLC 25,000$53,0000.04%
Virtu Financial LLC 25,166$54,0000.01%
D.A. DAVIDSON & CO. 108,500$231,0000.00%
J. Goldman & Co LP 26,300$56,0000.00%
TWO SIGMA ADVISERS, LP 361,401$770,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 49,500$105,0000.00%
View complete list of ONCOSEC MED INC shareholders